I
n stroke patients, imaging of the brain with CT or T2-weighted (T2-w) MRI is an important tool to distinguish between hemorrhagic and nonhemorrhagic stroke. Once the presence of an intracranial hemorrhage is excluded, imaging can also help to classify the stroke subtype by determining the site and size of the ischemic lesion. Eventually, visualization of the lesion may help to predict the functional consequences of the event.
In the ealy stage of ischemia, CT is the technique of choice to distinguish between hemorrhagic and nonhemorrhagic stroke. However, with CT 30% to 60% of the ischemic lesions are still invisible in the acute stage. [1] [2] [3] [4] During the first 24 hours after an ischemic stroke, proton density-weighted (PD-w) and T2-w MRI have 20% to 30% false-negative results. [5] [6] [7] This percentage increases to 30% to 50% during the first 3 to 6 hours after stroke. 3, 8 As a consequence, CT or conventional MRI is not generally used to predict the presence and extent of ischemic damage in the acute stage after stroke.
Cytotoxic edema, which is caused by the accumulation of intracellular water due to cell membrane damage minutes after onset of acute cerebral ischemia, causes a restriction of microscopic proton diffusion. In diffusion-weighted MRI, this decrease in water diffusion is presumably reflected in a decrease of the apparent diffusion coefficient (ADC) on ADC trace maps, 9 -15 which is visualized as a hyperintensity on the diffusion-weighted images (DWI). 12, 14, 15 Previous animal studies showed that DWI is able to visualize cerebral ischemic changes within 5 minutes 9 to 1 to 3 hours after onset of symptoms. 10,16 -19 In humans, ischemic changes were detected with DWI as early as 2 to 6 hours after onset of symptoms. 15,20 -22 Other advantages of DWI are the low number of false-negative investigations (5%), 23 the clear discrimination between ischemic lesions and the nonischemic brain, 11, 15, 24 and the discrimination between acute and chronic ischemic lesions. 11, 23 With these features, DWI facilitates the determination of the type, site, and extent of cerebral ischemia at an early stage. This might help to predict the clinical outcome of stroke patients.
Recent studies showed that in the acute stage after stroke, DWI is more sensitive for early ischemic changes than T2-w MRI. 11,14,15,20 -22,25 However, other studies showed that both PD-w imaging 6, 8 and fluid-attenuated inversion recovery (FLAIR) imaging 26, 27 are superior to T2-w imaging in the detection of acute ischemic lesions. Therefore, DWI should be compared with PD-w and FLAIR imaging as well. The purpose of this observational study was to evaluate the use of DWI in the early phase (Ͻ60 hours after onset of symptoms) of ischemic stroke. We therefore investigated the sensitivity of DWI in detecting early cerebral ischemic changes in comparison with T2-w, PD-w, and FLAIR MRI scans. Furthermore, we assessed the prognostic value of lesion volume on early DWI scans with respect to final infarct volume and clinical outcome. Finally, we assessed the prognostic value of ADC measurements in ischemic lesions with respect to clinical outcome.
Subjects and Methods

Patients and Controls
Between October 1996 and November 1997 we investigated 47 patients in the early phase of hemispheric ischemia (Ͻ60 hours after onset), as diagnosed by a neurologist. After a routine CT scan was performed, MRI was performed after informed consent was obtained from the patient or a representing family member. Patients who needed artificial respiration and patients who were otherwise unable to undergo the MR examinations were excluded. Four patients were treated with low, intermediate, or high intravenous doses of heparinoid (Org 10172, Organon) as part of the EuroTOAST (Trial of Org 10172 in Acute Stroke Treatment) investigation (Table 1,  patients 8, 10, 12, and 14) . Otherwise, patients received aspirin (nϭ32) or oral anticoagulants (nϭ6) together with conventional supportive therapy for acute stroke. Patients receiving experimental neuroprotective agents were not included.
The control group consisted of 9 men and 6 women who had no history of ischemic neurological deficits and had no other intracranial diseases (mean age, 43 years; range, 22 to 71 years). They underwent the same DWI protocol as the patients. The study was approved by the Human Research Committee of our hospital.
MR Protocol
All MR investigations were performed on a 1.5-T clinical imaging system (Philips Gyroscan ACS-NT 15 whole-body system, Philips Medical Systems) in the early phase (Ͻ60 hours) after onset of symptoms. A sagittal spin-echo T1-weighted sequence (repetition time [TR] , 427 ms; echo time [TE], 12 ms; 16 slices; slice thickness, 7.0 mm; 0.7-mm interslice gap; 1 average), an axial spin-echo PD-w and T2-w sequence (dual-echo T2-w MRI: TR, 2014 ms; TE, 30 ms and 100 ms; 19 slices; slice thickness, 7.0 mm; 0.7-mm interslice gap; 1 average; matrix size, 256ϫ256; scan reduction, 75%) and an axial FLAIR sequence (Turbo Spin Echo, turbo factor 11 [ie, acquiring 11 echoes per TR]; TR, 5496 ms; TE, 100 ms; inversion time, 2000 ms; 16 slices; slice thickness, 6.4 mm; 1.3-mm interslice gap; 2 averages, matrix size, 256ϫ256; reduced acquisition, 90% [90% of data points acquired]) were performed. For DWI, a fat-suppressed (Spectral Presaturation with Inversion Recovery), multishot, spin-echo/echo planar imaging sequence was used, with a pair of diffusion gradients centered around a 180°pulse (TE, 140 ms; TR, 667 or 1200 ms; 2 averages; matrix size, 128ϫ128; reduced acquisition, 75% [96 of 128 data points acquired]; echo planar imaging factor, 13 [13 readout gradients per TR]). To reduce motion artifacts, the head of the patient was supported with soft supportive wedges and straps. For the DWI scans, navigator echoes were used to compensate for patient movements during the acquisitions, and cardiac triggering was used to reduce artifacts from pulsatile brain motion. Use of this sequence permitted acquisition of 10 to 12 slices (depending on the heart rate), which allowed a total coverage of 72 to 86.4 mm of the brain (slice thickness, 6.0 mm; 1.2-mm interslice gap). DWI scans were acquired with diffusion gradients along each of the three principal axes with 3 different b values (0, 187, and 757 s/mm 2 ). For patient handling and performing the entire imaging protocol, Ϸ20 minutes were needed, of which Յ6 minutes were needed for DWI. A follow-up MRI or CT scan was made Ն6 days after the onset of symptoms. The follow-up MRI scan consisted of sagittal T1-w and axial PD-w, T2-w, and FLAIR scans. Total study time for the follow-up examination was Ϸ10 minutes.
Image Analysis
The early T2-w, PD-w, and FLAIR images were examined separately from the follow-up MRI scans by an experienced neuroradiologist (L.M.P.R.) without knowledge of the patients' symptoms and without reference to the DWI results. The ischemic lesions were measured on a separate workstation: areas of abnormal hyperintensity were traced on each slice of the PD-w (or FLAIR) images and on each slice of the DWI scans. These areas of abnormal hyperintensity were summed and multiplied with the slice thickness (plus interslice gap) to calculate the volumes of the acute ischemic lesions. To measure the lesion size on DWI scans we used the images that were acquired with the highest b value only, and all 3 diffusion directions were considered. Hyperintensities that were visible on only one or two diffusion directions were not considered ischemic lesions, since these hyperintensities are most likely to be caused by diffusion anisotropy. 28 -30 If patients had 2 fresh ischemic lesions, the volumes of both lesion were summed to analyze the prognostic value of infarct volume on clinical outcome. Preexistent cerebral infarcts were not included in these measurements.
ADC Measurements
ADC trace maps were calculated off-line afterward on the basis of the DWI that were acquired over the 3 principal axes. 13 Measurements of the ADC of normal-appearing brain were obtained in patients and in controls from various regions of interest. Regions of interest were between 100 and 300 mm 2 in size and were carefully placed in an attempt to exclude sulcal or intraventricular cerebrospinal fluid, which has a high ADC value. To calculate the mean ADC of ischemic lesions (ADC lesion ), the region of interest outlining the ischemic lesion on DWI was transferred to the corresponding ADC trace map. Ratios were calculated between the ADC of normalappearing brain in the right and left hemispheres and between the ADC of the ischemic area and the corresponding contralateral region.
Clinical Assessment
In the early stage, the patients' clinical status was determined with the National Institutes of Health Stroke Scale (NIHSS) 31 and the modified Rankin Scale (RS). Long-term clinical outcome was determined with the NIHSS, RS, and Barthel Index (BI). The NIHSS is a serial scale of neurological deficit that measures 11 items of the patients' neurological status. The reliability of the NIHSS was previously demonstrated in a number of studies. [31] [32] [33] [34] [35] [36] We used the 31-point scale proposed by Goldstein et al. 31 The modified RS 37 is a simplified overall assessment of function. A score of 0 indicates no symptoms, and a score of 5 indicates severe disability. In this study a RS score of 0 to 3 was considered good outcome, whereas a RS score of 4 or 5 was considered poor outcome. The BI 38 is a reliable and valid measure of the ability to perform activities of daily living such as eating, dressing, bathing, walking, and using the toilet. A score of 100 indicates no disability, and a score of 0 indicates severe disability.
Statistical Analysis
For statistical analysis, paired analysis of differences was performed with the Students' t test (after the F test was performed) or with the nonparametric Wilcoxon rank sum test. The paired samples t test was used for comparison of infarct volumes. Infarct volumes are expressed as mean and range. Pearson correlations were calculated between lesion volumes on the early MR images and follow-up scans. Spearman rank correlations were calculated between lesion volume and clinical outcome ratings. For the 2 test, the Yates correction for continuity was used. For the comparison of outcome ratings between patients with large or small acute ischemic lesions and between patients with high or low ADC of the acute infarct, the Mantel-Haenszel 2 test was used. A value of PϽ0.05 was considered statistically significant. Statistical significance was corrected for repeated measures. Receiver operating characteristics analysis was used to calculate the lesion volume, which determines clinical outcome of patients with optimum sensitivity and specificity.
Results
Forty-seven patients initially fulfilled our inclusion criteria, but 3 patients were too uncooperative to undergo the MRI examination, and in 2 patients the DWI failed because of patient motion (nϭ1) or technical problems (nϭ1). We therefore analyzed the results of 42 patients with signs and symptoms of hemispheric ischemia of acute onset (25 men, 17 women; mean age, 64 years; range, 36 to 85 years). The demographic data and current clinical symptoms are shown in Table 1 . Before the current ischemic event, 9 patients (21%) had suffered from a minor ischemic stroke and 8 patients (19%) had suffered from a transient ischemic attack (TIA). The mean time between the onset of symptoms and the early MR investigations was 23 hours (range, 1.5 to 60 hours). Five patients were imaged in the hyperacute stage (Ͻ6 hours after onset), 5 patients were imaged between 6 and 12 hours after onset, 15 patients were imaged between 12 and 24 hours, and 17 patients were imaged between 24 and 60 hours after onset of symptoms. The mean time between the onset of symptoms and the follow-up MRI was 17 days (range, 6 to 49 days). In 3 patients a follow-up CT scan was performed instead of an MRI (patients 5,12, and 42).
The results for the detection of lesions on early T2-w, PD-w, FLAIR, and DWI scans are summarized in Table 2 . For this analysis, the follow-up scans were used as the gold standard. Four of the 42 patients (10%) had no lesion evident on the follow-up scans. These patients had transient symptoms and also had no lesions on the early MRI or DWI scans. In 7 patients, 2 infarcts were found on the follow-up MRI. Thus, a total of 45 infarcts were analyzed. During the first 60 hours after stroke, more lesions were detected on the DWI scans (98%) than on the T2-w images (71%; Pϭ0.002, No false-positive lesions were found with DWI: all hyperintensities resembling an ischemic lesion on DWI evolved into infarcts on the follow-up scan. A typical example of DWI, T2-w, and PD-w scans of a patient in the hyperacute stage after stroke is shown in Figure  1 . Figure 2 shows the DWI, T2-w, PD-w, and FLAIR scans of another patient who was imaged 22 hours after the onset of symptoms.
In Table 3 , the sizes of the lesions as measured on the DWI scans, the early PD-w/FLAIR scans, and the follow-up MRI scans are summarized. The 3 patients with a follow-up CT scan only were excluded from this analysis. The mean lesion volume was significantly larger on the DWI scans (35 mL) than on the early PD-w/FLAIR images (21 mL) if patients were imaged between 0 and 12 hours after onset of symptoms (PϽ0.05). In patients who were imaged within 6 hours after stroke the difference in lesion size on the DWI scans (34 mL) and on the PD-w/FLAIR images (15 mL) appears to be even more profound than in patients who were imaged between 6 and 12 hours (36 mL versus 27 mL, respectively). However, this difference did not reach statistical significance because of the limited number of patients. No significant differences in mean lesion volume between the DWI scans and PD-w/ FLAIR images were found if patients had the first MRI investigation between 12 and 24 hours after onset of symptoms or Ն24 hours. Lesions were significantly smaller on the early DWI scans (mean lesion size, 35 mL) than on the follow-up MRI scans (mean lesion size, 45 mL) if patients were imaged Ͻ12 hours after onset of symptoms (PϽ0.05). Again, in patients who were imaged Ͻ6 hours or between 6 and 12 hours after onset of symptoms, the difference in lesion size did not reach statistical significance because of the small sample size. The mean volume of lesions imaged Ն12 hours after onset of symptoms was not significantly altered on the follow-up scans.
Long-term clinical outcome was measured between 7 and 33 weeks after onset of symptoms (mean, 17 weeks). During the follow-up period, 4 patients died. One patient with an infarct on follow-up MRI died from a pneumonia 3 months after onset of symptoms; another patient died from a retroperitoneal bleeding 2 weeks after the cerebral infarct. The other 2 patients had transient symptoms of cerebral ischemia without signs of an ischemic infarct on DWI or follow-up scan. One of these 2 patients died from a recurrent stroke in the posterior fossa 2 Figure 1 . Fifty-five-year-old man with an acute left-sided hemiparesis 6 hours before the first MRI examination (patient 10). On the early PD-w (A) and T2-w (B) images, no ischemic lesion was visible. The early DWI scan (C) shows a right-sided hyperintensity in the frontal lobe (territory of the pericallosal artery), which can be appreciated as a hypointensity on the ADC trace map (D). The follow-up MRI (E) was performed 6 days after the onset of symptoms and confirms the infarct. However, on the follow-up scan the infarct extended into the corpus callosum. weeks after a hemispheric TIA; the other patient died from an unknown cause 3 months after the TIA. These 4 patients were excluded from further analysis because the baseline ischemic event was not the direct cause of their death. Spearman rank sum correlations of lesion volume, as measured on the early DWI scans and on the follow-up MRI scans, versus clinical outcome ratings are shown in Table 4 . The corresponding data are plotted in Figures 3 through 5 . Lesion volume on the early DWI scans correlated significantly with the early NIHSS and RS scores (nϭ38, Figure 3 ) and with the long-term clinical outcome ratings (nϭ38, Figure 4 ). Lesion volume on the follow-up MR scans correlated significantly with the long-term clinical outcome ratings as well (nϭ36, Figure 5 ). The correlations between lesion volume on the early DWI scans and long-term clinical outcome ratings were increased when the 9 patients who had an ischemic event before the current event were excluded from the analysis: NIHSS: rϭ0.71, PϽ0.001; RS: rϭ0.70, PϽ0.001; BI: rϭϪ0.55, PϽ0.001.
In Figure 6 , patients are grouped by the volume of the ischemic lesion on DWI. Patients with a relatively good outcome (nϭ29) had significantly smaller ischemic lesions on DWI scans (mean lesion volume, 18 mL) than patients with a poor outcome (nϭ9; mean lesion volume, 92 mL; PϽ0.05). With receiver operating characteristics analysis, a lesion volume of Յ22 mL on early DWI scans was found to determine the patients' outcome to be good with a sensitivity of 79% and a specificity of 89% (95% CI, 0.70 to 0.95). Clinical outcome ratings were significantly worse in patients with infarcts Ͼ22 mL on DWI than in patients with smaller infarcts (NIHSS: Pϭ0.001; BI: Pϭ0.01; RS: Pϭ0.001; Figure 5 ). When the 9 patients who previously suffered from an ischemic stroke were excluded from this analysis, the sensitivity and specificity were 75% and 100%, respectively (95% CI, 0.78 to 0.98). Table 5 summarizes the ADC values of patients and control subjects. In both patients and controls, ADC measurements were performed in various normal-appearing parts of the brain. No significant difference in mean ADC was found between patients and controls in corresponding normal-appearing areas in the cerebrum. No significant difference in ADC was found between the various regions in the brain parenchyma of patients or controls. The mean ADC of the ischemic lesions (ADC lesion ) was 29% lower than the mean ADC in corresponding areas of the contralateral hemispheres (ADC contralateral ; PϽ0.001). Significant correlations were found between the ADC ratio (ADCrϭADC lesion /ADC contralateral ) and the follow-up NIHSS, BI, and RS scores (Table 4) . Patients with a poor outcome had a significantly lower ADCr of the ischemic lesions (mean ADCrϭ0.59Ϯ0.14) than patients with a good outcome (mean ADCrϭ0.77Ϯ0.15). An ADCr limit of 0.62 was found to determine the patients' outcome to be good or poor with a sensitivity of 83% and a specificity of 75% (95% CI, 0.66 to 0.94). Patients with low ADCr (Ͻ0.62) had significantly worse clinical outcome than patients with high ADCr (Ն0.62, NIHSS: Pϭ0.024; BI: Pϭ0.001; RS: Pϭ0.005).
Discussion
Our results confirm that DWI is a useful imaging method to detect ischemic lesions in the early stage after stroke. All but one of the infarcts on follow-up MRI were depicted as a hyperintense lesion on DWI, whereas with T2-w or PD-w imaging, 29% and 20% of lesions, respectively, were not found in the early stage. Although less accurate than DWI, the FLAIR imaging provided better results in detecting ischemic lesions than the T2-w or PD-w scans.
The volume of the lesions that were imaged within the first 12 hours after onset of symptoms was significantly increased on the follow-up MRI. Enlargement of cerebral infarcts has been demonstrated previously by Baird and coworkers, 39 who defined lesions that were Ն20% larger on follow-up MRI scans than on early DWI scans as significantly enlarged. When we analyzed our data accordingly, 41% of the lesions were significantly enlarged, which is comparable to the 43% reported by Baird et al. A probable explanation for the enlargement of the ischemic lesions is that areas surrounding the core of the lesion became infarcted after we performed the MRI investigation. 40 Another explanation for lesion enlargement is the presence of vasogenic edema. Since we performed the follow-up examination between 6 and 49 days (mean, 17 days) after onset of symptoms, vasogenic edema surrounding the infarcted area may have mimicked lesion enlargement.
Our finding that patients with poor outcome had larger lesions than patients with good outcome was confirmed in a previous study in which early T2-w MRI was used. 41 Compared with our results, similar correlations were reported between lesion volume on T2-w images and follow-up BI score 42 and between infarct size on CT scans, performed between 7 and 10 days after stroke, and the NIHSS score at 3 months after the onset of symptoms. 1 The observed correlations between lesion volume on early DWI scans and clinical severity ratings have been described before 21, 43 and suggest that lesion volume can be predictive of the clinical outcome of stroke patients, particularly in patients without previous ischemic strokes.
For our entire patient population, good outcome could be predicted with a sensitivity of 79% and a specificity of 89% if patients had ischemic lesions of Յ22 mL on early DWI scans. One of our patients had very poor clinical outcome ratings, although she only had a small infarct. This patient had suffered from an ischemic stroke in the contralateral hemisphere 2 years earlier, from which she was left with a mild left-sided hemiparesis. The presence of infarcts in both hemispheres explained her low clinical outcome ratings. In patients who had never suffered from an ischemic event before or patients who previously had a TIA only, good outcome could be predicted with a specificity of 100%. This means that all patients without a previous stroke had good outcome if the acute ischemic lesion was Յ22 mL. These results show that lesion size measurements on early DWI scans can provide prognostic information to the clinician. Early information about the prognosis of acute stroke patients is useful if acute treatment with tissue plasminogen activator is considered. 44 One might speculate that patients with ischemic lesions Յ22 mL on DWI scans should not be treated with tissue plasminogen activator because the potential benefit is not outweighed by the risk of complications. However, the presented cutoff value of 22 mL should be interpreted with care because ischemic lesions tend to increase in size during the first 12 hours after onset of symptoms. To establish a critical lesion size in the hyperacute stage after stroke (0 to 6 hours), more patients should be investigated.
Our measurements of the ADC were reproducible in controls and in normal-appearing white and gray matter areas of stroke patients. Our ADC measurements of normalappearing brain tissue were in the same range as the ADC measurements of other studies in human stroke patients. [11] [12] [13] 15, 20, 22, 45, 46 Marks and coworkers 15 reported that the ADC varies within ischemic lesions. Our experience confirmed this finding. In our patient population the ADC varied widely between various locations within ischemic lesions, and the ADC was usually lower in the lesion core than in more peripheral parts. A number of studies 11, 12, 20, 22, 46 determined the ADC of the core of the lesion only, whereas in our study the mean ADC was determined over an entire slice of the ischemic region. This might explain why in our study the ADCr between ischemic regions and corresponding contralateral areas were higher than the ADCr reported else- where. 11, 12, 20, 22, 46 The presence of cerebrospinal fluid in the investigated regions might have caused variations in the ADC as well. The variations in ADC within ischemic lesions might become an important issue for future research in acute stroke patients. Animal studies indicate that the variation in ADC corresponds with regional cerebral blood flow, 19 the severity 47 and extent 9, 47 of neuronal damage, and the degree of regional metabolic alterations. 10 These data suggest that DWI can depict not only severely ischemic lesions but also moderately compromised regions that might be salvageable if therapeutic intervention is applied.
The DWI technique used in this study required 1.5 to 2 minutes for each diffusion direction, which is longer than is required by DWI techniques reported elsewhere. 12, 14, 20, 22 In our study prolonged scan time was a trade-off with the signal-to-noise ratio and the number of slices. A disadvantage of longer scan time is the higher susceptibility to motion artifacts. However, even though we used this relatively long DWI technique, only 1 patient had to be excluded from our study because of motion artifacts.
We conclude that DWI is a more reliable imaging method than MRI in detecting ischemic lesions in acute stroke patients. Lesion size, as measured on DWI scans, appears to be a potential parameter for predicting clinical outcome in acute stroke patients. 
